Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 9:30 PM
Ignite Modification Date:
2025-12-24 @ 9:30 PM
NCT ID:
NCT01174732
Eligibility Criteria:
Inclusion Criteria:
* With mild-to-moderate persistent asthma for at least 6 months and having used inhaled beta-agonist for asthma control;
* Must demonstrate response to beta 2 agonist by Reversing;
* Must demonstrate ability to use DPI;
* Females of child-bearing potential must be non-pregnant, non-lactating, and practicing a clinically acceptable form of birth control;
* Additional Criteria
Exclusion Criteria:
* Smoking history of ≥ 10 pack-years, or having smoked within 6 months;
* Upper respiratory tract infections
* Asthma exacerbations;
* Known intolerance or hypersensitivity to any of the ingredients of the study drug or Proventil®;
* Use of prohibited drugs or failure to observe the drug washout restrictions;
* Having been on other clinical drug/device studies in the last 30 days;
* Other Criteria
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
55 Years
Study:
NCT01174732
Study Brief:
Protocol Section:
NCT01174732